Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 2Phase EARLY_PHASE1 2Phase 3 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Withdrawn 1Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma, Capillary 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Propranolol × Clear all
NCT01056341 2015-12-10

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Pierre Fabre Dermatology

Phase 2/3 Completed
512 enrolled 13 charts

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡